Historical record - last NADAC effective date: 6/17/2020
Product Information
OMEPRAZOLE DR 40 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0680 per EA under NDC 57237016201. Its NADAC has been published 194 times since Oct 19, 2016.
FDA first approved this application on Aug 19, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237016201
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
6/17/2020
Active Ingredients
OMEPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203270FDA Approved
8/19/2015
TE Code
AB
On Market Since
8/19/2015
Pharmacological Classes
Price Statistics
The NADAC for OMEPRAZOLE DR 40 MG CAPSULE has been published 194 times since Oct 19, 2016, and over the history we have for it it has declined 37.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0680 per EA |
|---|---|
| All-time high | $0.1284 (Jan 11, 2017) |
| All-time low | $0.0642 (Dec 19, 2018) |
| Median price | $0.0743 |
| Average price | $0.0812 |
| Largest weekly change | +17.9% (May 22, 2019) |
| Weeks tracked | 194 |
| Tracking since | Oct 19, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-37.3%
Last surveyed Jul 1, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OMEPRAZOLE DR 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE DR 40 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.0680 per EA (NDC 57237016201), effective Jul 1, 2020.
How has the price of OMEPRAZOLE DR 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OMEPRAZOLE DR 40 MG CAPSULE has declined 37.3%. It has been tracked across 194 weekly CMS publications since Oct 19, 2016.
What are the highest and lowest recorded NADAC prices for OMEPRAZOLE DR 40 MG CAPSULE?
Since Oct 19, 2016, the NADAC for OMEPRAZOLE DR 40 MG CAPSULE has ranged from a low of $0.0642 (Dec 19, 2018) to a high of $0.1284 (Jan 11, 2017), with a median of $0.0743 per EA.
Are there cheaper alternatives to OMEPRAZOLE DR 40 MG CAPSULE?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OMEPRAZOLE DR 40 MG CAPSULE, is $0.0494 per EA — about 27% below OMEPRAZOLE DR 40 MG CAPSULE.
Who manufactures OMEPRAZOLE DR 40 MG CAPSULE?
OMEPRAZOLE DR 40 MG CAPSULE (NDC 57237016201) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.